Specialised Therapeutics’ breast cancer drug gets Philippines FDA approval
In a Phase III ExteNET trial, neratinib offered a 34% decline in the risk of recurrence versus placebo at two…

In a Phase III ExteNET trial, neratinib offered a 34% decline in the risk of recurrence versus placebo at two…
Two 50μg doses of the vaccine showed to stimulate a robust immune response for children aged six to 11 years.
The vaccine is intended for the immunisation of children aged six years and above against Covid-19.
Serum Institute of India will manufacture and commercialise the vaccine as Covovax in the Philippines.
CytoDyn is set to submit the Phase III CD12 trial results of Vyrologix as Covid-19 treatment to different regulatory agencies.
The Philippines Department of Health (DOH) has adopted the Food and Drug Administration’s (FDA) recommendation to temporarily put the use…
The Food and Drug Administration of the Philippines has given approval to Sputnik V Covid-19 vaccine for emergency use, as…
Chinese company Sinopharm has submitted an application to the Food and Drug Administration (FDA) of the Philippines for emergency use…
Thank you for subscribing to Pharmaceutical Technology